Akari Therapeutics

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31
Revenue
$0
$0
Gross Profit
-12
EBITDA
-7,507
-5,976
EBIT
-7,449
-5,988
Net Income
-7,558
-5,566
Net Change In Cash
0
0
Free Cash Flow
-4,894
-4,043
Cash
4,177
1,310
Basic Shares
9,418
6,726

Annual Financials

Values in thousands 2022-12-31 2021-12-31 2020-12-31
Revenue
$0
$0
$0
Gross Profit
-3
-4
-8
EBITDA
-23,084
-17,210
-20,444
EBIT
-23,087
-17,214
-20,453
Net Income
-6,972
-17,606
-17,597
Net Change In Cash
0
0
0
Free Cash Flow
-21,504
-18,846
-16,951
Cash
13,249
9,361
14,056
Basic Shares
3,121
2,146
1,579

Earnings Calls

Quarter EPS
2024-06-30
-$0.80
2024-03-31
-$0.82
2023-09-30
$0
2023-06-30
$0